コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ld it be required for the later treatment of acquired heart disease.
2 of infants and children with congenital and acquired heart disease.
3 es for cardiac repair in both congenital and acquired heart disease.
4 ds of pediatric patients with congenital and acquired heart disease.
5 ucidating the pathogenesis of congenital and acquired heart diseases.
6 therapeutic implications for congenital and acquired heart diseases.
7 generative therapies targeting congenital or acquired heart diseases.
8 stem cell-based therapies for congenital and acquired heart diseases.
9 rrantly regulated in a large-animal model of acquired heart disease and in failing human myocardium.
10 form the treatment of congenital, as well as acquired, heart disease and likewise would enable develo
12 ht ventricle (RV) is of lesser importance in acquired heart disease, but its role is of increasing im
13 phan disease, its role as a leading cause of acquired heart disease in children has led to significan
14 ported worldwide and is the leading cause of acquired heart disease in children in developed countrie
16 se is recognized as the most common cause of acquired heart disease in children in the developed worl
21 Kawasaki disease, the most common cause of acquired heart disease in developed countries, is a self
22 tion, KD has become the most common cause of acquired heart disease in the pediatric age group in dev
23 heter therapy in children with congenital or acquired heart disease is a challenging, innovative, and
24 heter therapy in children with congenital or acquired heart disease is a challenging, innovative, and
26 al child and in the child with congenital or acquired heart disease, was a primary focus of pediatric
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。